Vestigo: ASPIRE data science internship provides mutual benefits to companies and students
DecodeHealth2024-07-19T12:47:49-05:00As published by Vestigo, Issue 5, Winter 2023 Read the full Vestigo issue, here.
As published by Vestigo, Issue 5, Winter 2023 Read the full Vestigo issue, here.
Imagine a world where predicting disease, tailoring treatments, and improving patient outcomes are no longer aspirational goals but everyday realities. The field of genomics holds this potential and is modernizing medicine in ways we could only dream of a decade ago. Public access to genomics data is transforming fields like artificial intelligence (AI), biotechnology, and drug discovery. Decode Health is leveraging publicly available resources to mine a wide range of multiomics and clinical data sources efficiently, developing a best-in-class approach to discover new solutions for detecting, monitoring, and treating diseases more effectively.
This study aims to identify RNA biomarkers distinguishing neuromyelitis optica (NMO) from relapsing-remitting multiple sclerosis (RRMS) and explore potential therapeutic applications leveraging machine learning. Read the full publication at www.jmdjournal.org
This article is written in response to "AI in Pharma: The Growing Number of Pharmaceutical Use Cases" by Nick Wichert of High Alpha Innovation
2024 CMSC Conference Presentation
2024 CMSC Conference Presentation
2024 CMSC Conference Presentation
Decode Health deployed its biomarker discovery platform, incorporating machine learning, to provide new insights into multiple sclerosis (MS) and neuromyelitis optica (NMO). The Decode platform identified disease-specific RNA biomarkers and connections between RNA expression [read more...]
November 2023 – Poster Presentation
Inc., known for its insightful coverage of innovative businesses and start-up companies, acknowledges the fastest-growing private entities in the United States. Decode Health was recognized as one of Inc.’s top 100 companies of 2024, driving [read more...]
As Seen In